Increasing prevalence of blood cancer including leukemia, and surging demand for early diagnosis and treatment monitoring are major factors driving market revenue growth.
Increasing prevalence of blood cancer including leukemia, and surging demand for early diagnosis and treatment monitoring are major factors driving market revenue growth
The global hematology diagnostics market size is expected to reach USD 5,758.6 Million in 2030 and register a revenue CAGR of 4.9% during the forecast period, according to latest report by Reports and Data. Demand for hematological diagnostics is expected to increase, owing to rising awareness about blood disorders among healthcare providers and patients, which is expected to drive market revenue growth over the forecast period.
Hematology diagnostic procedures are widely used to diagnose blood-related disorders such as anemia, blood cancer such as leukemia, and bleeding disorders such as blood clotting disorders and hemophilia. Apart from disease detection, hematology diagnostics aid in proper blood count and characterization of blood cells. The widely used hematology diagnostic systems include hemostasis, immunohematology, hematology reagents, and hematology rapid tests.
Hematology refers to the study of blood, blood-related diseases, and blood components, and hematology diagnostics include a wide array of advanced hematology tests performed using whole blood, urine, serum, cerebrospinal fluid, and other bodily fluids. These tests involve use of different In Vitro Diagnostic (IVD) technologies, such as flow cytometry, blood analysis, immunodiagnostics, hemostasis, and molecular diagnostics, to diagnose problems pertaining to blood and its components, including red blood cells, white blood cells, lymph, plasma, and platelets.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4057
Use of hematology diagnostics has increased in recent times, owing to increasing incidence of blood disorders. Factors such as an aging population, technological developments, and increasing need for better healthcare facilities are likely to boost the global hematology diagnostics market. The global market is also being driven by increasing government initiatives across the world to boost healthcare infrastructure. However, high costs of diagnostics and lack of coverage for diagnostic procedures in health insurance plans in many countries are two major challenges limiting revenue growth of the global hematology diagnostics market. Moreover, lack of public awareness about hematology diagnostics is also expected to restrict market revenue growth to some extent.
Several new products and technologies have been introduced in the market in recent times, which are expected to revolutionize laboratory hematology workflow and standards. The capabilities of new automated technologies to go beyond established approaches, such as cellular analysis and manual assessment, are expected to increase adoption of hematology diagnostics.
Some Key Highlights from the Report:
- Based on product type, the consumables segment is expected to account for largest revenue share and register the fastest growth rate during the forecast period, due to low manufacturing costs, increasing availability of consumables for certain analyzer tests, and increase in the number of tests needed by consumers. In hematology analyzers, consumables are utilized to lyse red blood cells from blood samples prior to leukocyte examination. Direct dependency of hematology tests on consumables is one of the main factors to drive revenue growth of the segment during the forecast period. Rising awareness about blood disorders among healthcare professionals and patients is also expected to increase demand for hematology analyzers and in turn, demand for consumables.
- Based on test type, the full blood count testing segment is expected to register a significantly faster growth rate over the forecast period. Full blood count tests are useful for general evaluation of health during routine check-ups, and they evaluates three major components found in the blood - white blood cells, red blood cells, and platelets. Several conditions, such as anemia, allergy, vitamin and iron deficiencies, and infections, can be easily diagnosed with the help of these tests.
- Based on end user, the hospitals & clinics segment is expected to register the fastest revenue CAGR over the forecast period. Hospitals & clinics segment is expected to lead in terms of revenue share over the forecast period, due to increase in demand for hematology diagnostics among individuals who require routine blood testing, such as diabetics and cancer patients. Moreover, This segment is expected to register a rapid growth rate, which can be attributed to a larger patient influx in hospitals as compared to other healthcare facilities and increasing number of registered hospitals across the globe.
- The Asia-Pacific market is expected to register the fastest revenue growth rate in the global market during the forecast period. Rapid urbanization, increasing incidence of chronic diseases, such as cancer and hematological diseases, particularly in developing countries including India and China, and improving healthcare infrastructure are some major factors driving revenue growth of the market in Asia-Pacific. According to the National Institute of Cancer Prevention and Research (NICPR), over 1.1 million cancer cases are recorded in India each year. Thus, high prevalence of cancer in various countries in the region is expected to increase demand for hematology diagnostics in Asia-Pacific.
- Key market players operating in the global market are Abbott Laboratories, Beckman Coulter, Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Drew Scientific Inc., Bio-Rad Laboratories Inc., HemoCue AB, Horiba Ltd., EKF Diagnostics, and Nihon Kohden Corporation, among others.Major companies operating in the market are focusing on various strategies, such as new product launches, acquisitions, and mergers to strengthen their market position and expand revenue shares.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/hematology-diagnostics-market
For this report, Reports and Data has segmented the global hematology diagnostics market based on product type, test type, end user, and region:
Product Type Outlook (Revenue, USD Million, 2019 - 2030)
- Instruments
- Consumables
Test Type Outlook (Revenue, USD Million, 2019 - 2030)
- Full Blood Count Testing
- Hemoglobin Testing
- Blood Glucose Testing
- Renal Profiling
- Vitamin B12 Deficiency Testing
- Other Test Types
End User Outlook (Revenue, USD Million, 2019 - 2030)
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/4057
Regional Outlook (Revenue, USD Million, 2019 - 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4057
Some points on how the report benefits stakeholders:
- The reports include historical (2019–2020) and forecast (2021–2030) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Automated Breast Ultrasound System (ABUS) Market Size, Share & Analysis, By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner, Others) By Application (Hospitals, Diagnostics Imaging Laboratories, Clinics, Others) And By Region Forecast To 2028
Automated Immunoassay Analyzers Market Size, Share & Analysis, By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme-Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay, Others) By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing, Others), And By Region Forecasts To 2028
Rheometers and Viscometers Market Size, Share & Analysis, By Product Type (Dynamic Rotational Rheometers, Torque Rotational Rheometers, Oscillatory Rheometers, Capillary Rheometers, Capillary Viscometers, Rotational Viscometers, Process Viscometers, Others), By Sample Type (Resins & Coatings, Suspensions & Slurries, Pastes & Gels, Others), By End-User (Pharmaceutical, Biotechnology, And Cosmeceutical Companies, Petroleum Product Manufacturers & Petrochemical Refineries, Food And Beverage Manufacturers, Others), And By Region Forecast To 2028
Vascular Graft Market Size, Share & Analysis, By Type (Haemodialysis Grafts, Coronary Artery Bypass Grafts, Peripheral Vascular Grafts, Coronary Stents, Others), By Raw Material (Polyester Grafts, ePTFE, Polyurethane Grafts, Biosynthetic Grafts), By Application (Coronary Artery Bypass, Aneurysms, Renal Bypass, Chronic Total Occlusion), And By End-Use (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Others), And By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-hematology-diagnostics-market